Koers MYND Life Sciences Inc. OTC Markets
Aandelen
MYNDF
CA62857B1094
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0249 USD | +17,45% |
|
-.--% | -20,19% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 717K 669K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,8 mln. | Nettowinst (verlies) 2023 | -1 mln. -933K | EV/omzet 2022 | - |
Nettoschuld 2022 | 2,59 2,41 | Nettoschuld 2023 | 3 2,8 | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,05
x | K/w-verhouding 2023 |
-0,47
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 40,17% |
1 dag | +17,45% | ||
3 maanden | +9,69% | ||
6 maanden | +24,50% | ||
Lopend jaar | -20,19% |
![Extreem 0.0152](/images/extremecours_fleche.png)
![Extreem 0.0152](/images/extremecours_fleche.png)
![Extreem 0.0129](/images/extremecours_fleche.png)
![Extreem 0.0129](/images/extremecours_fleche.png)
![Extreem 0.0129](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 26-11-20 |
Lyle Oberg
FOU | Founder | 63 | 06-07-18 |
Founder | 65 | 06-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 65 | 06-07-18 | |
Lyle Oberg
FOU | Founder | 63 | 06-07-18 |
John Campbell
CEO | Chief Executive Officer | 53 | 26-11-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,42% | 122 mld. | |
+19,02% | 113 mld. | |
+3,35% | 22,66 mld. | |
-11,63% | 16,68 mld. | |
-16,57% | 16,61 mld. | |
-39,57% | 16,92 mld. | |
+2,68% | 13,62 mld. | |
+21,16% | 11,04 mld. | |
+108,78% | 10,43 mld. |
- Beurs
- Aandelen
- Koers MYND
- Koers MYNDF